Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis.
about
A Possible Role of Intestinal Microbiota in the Pathogenesis of Ankylosing SpondylitisCross-talk between type 3 innate lymphoid cells and the gut microbiota in inflammatory bowel disease.Immunomodulatory and anticancer potential of Gan cao (Glycyrrhiza uralensis Fisch.) polysaccharides by CT-26 colon carcinoma cell growth inhibition and cytokine IL-7 upregulation in vitro.A Single Nucleotide Polymorphism in the Il17ra Promoter Is Associated with Functional Severity of Ankylosing Spondylitis.Expansion of inflammatory innate lymphoid cells in patients with common variable immune deficiencyChildhood hospitalisation with infections and later development of ankylosing spondylitis: a national case-control study.An overview of investigational new drugs for treating ankylosing spondylitis.CD4 T lymphocyte autophagy is upregulated in the salivary glands of primary Sjögren's syndrome patients and correlates with focus score and disease activity.Developments with experimental and investigational drugs for axial spondyloarthritis.Pathogenesis of ankylosing spondylitis - recent advances and future directions.The Bench-to-Bedside Story of IL-17 and the Therapeutic Efficacy of its Targeting in Spondyloarthritis.Pathogenesis of ligaments ossification in spondyloarthritis: insights and doubts.Targeting the interleukin-23/17 axis in axial spondyloarthritis.Autoinflammation and HLA-B27: Beyond Antigen Presentation.Current perspective on the role of the interleukin-23/interleukin-17 axis in inflammation and disease (chronic arthritis and psoriasis).IgA-coated E. coli enriched in Crohn's disease spondyloarthritis promote TH17-dependent inflammation.Innate lymphoid cells in autoimmunity: emerging regulators in rheumatic diseases.Immune modules shared by innate lymphoid cells and T cells.Review: Innate Lymphoid Cells: Sparking Inflammatory Rheumatic Disease?Yin and yang of interleukin-17 in host immunity to infection.Management of patients with inflammatory bowel disease and spondyloarthritis.Dysregulation of Innate Lymphoid Cells in Common Variable Immunodeficiency.Brief Report: Group 3 Innate Lymphoid Cells in Human Enthesis.Macrophage Migration Inhibitory Factor Induces Inflammation and Predicts Spinal Progression in Ankylosing Spondylitis.Enthesitis: from pathophysiology to treatment.Differentially expressed mRNAs, lncRNAs, and miRNAs with associated co-expression and ceRNA networks in ankylosing spondylitis.Pathological and therapeutic roles of innate lymphoid cells in diverse diseases.Impact of vedolizumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV-IBD cohort.The role of innate lymphoid cells in health and disease.Spreading spondyloarthritis: are ILCs cytokine shuttles from base camp gut?Progress of genome-wide association studies of ankylosing spondylitis.IL-7 primes IL-17 in mucosal-associated invariant T (MAIT) cells, which contribute to the Th17-axis in ankylosing spondylitis.Spondyloarthritis, Acute Anterior Uveitis, and Fungi: Updating the Catterall-King Hypothesis.Correlation of serum MMP3 and other biomarkers with clinical outcomes in patients with ankylosing spondylitis: a pilot study.Clinical efficacy of α4 integrin block with natalizumab in ankylosing spondylitis.Cytokines and integrins related to inflammation of joint and gut in patients with spondyloarthritis and inflammatory bowel disease.Role of Subclinical Gut Inflammation in the Pathogenesis of Spondyloarthritis.Whodunit? The Contribution of Interleukin (IL)-17/IL-22-Producing γδ T Cells, αβ T Cells, and Innate Lymphoid Cells to the Pathogenesis of Spondyloarthritis.The role of secukinumab in the treatment of psoriatic arthritis and ankylosing spondylitis
P2860
Q28069331-4C395916-8DF9-474B-B243-1475FDC6600BQ35785264-E510ABD8-1E52-4DD9-9F8F-72A34E33D8F9Q36073299-87FF4ABC-888B-4030-9D4E-67691829B41BQ36077679-1574AAAA-BA6A-41F9-89A6-574B230C8ADAQ36900160-5B9B119C-DB25-4C9D-977A-24A5A0401421Q37358818-2C63BC92-6279-416E-81FD-A0490BBEFC25Q38631462-10C1A780-1206-41C5-9219-ED75B87A22A1Q38661852-746FE4FF-FA65-438F-9FBC-274FAB2CE913Q38676714-1119B593-2759-44BC-AAA0-DE2A684F9058Q38690443-40E50460-AE60-43BB-893A-BD047024896EQ38815070-6BD24E6F-E7A5-4704-9385-21306BF9B57DQ38816459-5209C5AE-3AC4-4259-B92D-3D0D3EE09A55Q38827500-118EA1CA-7580-42BC-BFCD-5E3C2FFB94BFQ38845301-59CA2052-BE1D-4696-872C-C0C98520B654Q38912297-39B8E6D2-6D4C-4EC1-9328-42C2B66D2CC9Q38971098-7AC0DAD3-820F-4E3C-BCA3-1C86C34D48B1Q38985676-C7239258-76AF-4848-81EC-33B527833AFCQ39000249-6E013FE6-770C-410F-B660-340EA4793E71Q39144086-81FCB65F-0C09-4FBB-8DAC-7A6A1C3ED1A5Q39438071-2CBA2E53-7EAB-4583-8FDE-3C90944D3DCBQ40054186-BA4F2E4B-9092-4B16-885F-420FB69E7E0DQ41990559-4047BE3F-CE08-4910-A224-D2BBC2987468Q46154278-B74C40D2-C148-4027-980F-0DA397459615Q46274917-8DD044D2-E946-476C-8C1C-FDBF4AEF75ACQ47329414-4A8011D4-E53A-43D3-B233-CBADA134FF5EQ47710960-45BA0078-C1E6-471C-9325-E76CDB0C6FC4Q47897160-C2C4A736-418F-4F6D-B8CE-E94DB6E28BAAQ48102896-2E40B48B-F9B0-4F6C-965B-27C282690611Q48146269-85FF2774-C005-45EF-8375-0A83A27DE428Q49124951-88562422-17C6-491C-AE06-47CC70764A9AQ49871790-8630B515-6836-4404-9F84-13149AE51A47Q49965650-7F528EF3-8388-4E5E-95B6-3BB953B49F84Q52575771-E9BA2364-8123-407E-82F0-69033AD52396Q53340748-02C2CECC-8406-489D-B407-C24D0A71EBA5Q54253244-71B70B4E-5FC1-4ABC-AC43-5FED8E27AFCEQ55027377-A70D9B1E-2919-495E-A339-C5E4B5B6EC3EQ55260711-203C240A-DCBC-4255-8AF1-7EBA354AEEB9Q55339808-06C4C001-3370-4656-942A-5B1A7E19CA5DQ58761666-B4669DB4-9330-49B6-A739-34E64071A556
P2860
Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Type 3 innate lymphoid cells p ...... s with ankylosing spondylitis.
@en
Type 3 innate lymphoid cells p ...... s with ankylosing spondylitis.
@nl
type
label
Type 3 innate lymphoid cells p ...... s with ankylosing spondylitis.
@en
Type 3 innate lymphoid cells p ...... s with ankylosing spondylitis.
@nl
prefLabel
Type 3 innate lymphoid cells p ...... s with ankylosing spondylitis.
@en
Type 3 innate lymphoid cells p ...... s with ankylosing spondylitis.
@nl
P2093
P2860
P50
P1476
Type 3 innate lymphoid cells p ...... ts with ankylosing spondylitis
@en
P2093
Alessandra Cannizzaro
AnnaRita Giardina
Aroldo Rizzo
Giacomo De Leo
Laura Saieva
Riccardo Alessandro
Sergio Peralta
P2860
P304
P356
10.1136/ANNRHEUMDIS-2014-206323
P407
P577
2015-04-22T00:00:00Z